功能性便秘和阻碍排便的功能性便秘
Mary T O'Donnell1, Sarah M Haviland2
1Department of General Surgery Walter Reed National Military Medical Center, Colon and Rectal Surgery Division, 8901 Rockville Pike, Bethesda, MD 20889, USA.
The Surgical clinics of North America
|April 27, 2024
概括
便秘涉及慢慢的结肠运动或排便问题,包括功能性便秘 (FC) 和受阻排便 (OD). 区分这些疾病是有效的,多学科的治疗策略的关键.
科学领域:
- 胃肠病学 胃肠病学
- 结肠直肠手术 结肠直肠手术
- 盆地地板治疗疗法 盆地底治疗
背景情况:
- 便秘的定义是结肠运动性下降或排便困难.
- 它可以表现为功能性便秘 (FC),结肠惯性,阻塞性排便 (OD) 或刺激性肠综合征-便秘类型 (IBS-CS).
研究的目的:
- 概述功能性便秘和受阻排便的诊断和管理方法.
- 强调区分这些疾病对于向治疗的重要性.
主要方法:
- 不包括IBS-便秘类型 (IBS-C).
- 多学科评估,涉及各种专家.
- 临床区分FC和OD之间的区别.
主要成果:
- 诊断和管理FC和OD需要一个团队方法.
- 专家包括营养学家,盆地治疗师,泌尿科医生和结直肠外科医生.
- 准确的区分指导治疗干预和预后.
结论:
- 有效管理FC和OD等便秘亚型,需要一个协调的,多学科的战略.
- 区分FC和OD对于优化患者的治疗结果至关重要.
- 这种方法可以改善复杂排便障碍的预后.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
160
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
160
Assessment of the Rectum and Anus
205
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
205
Chronic Bowel Disorders: Introduction
446
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
446
Inflammatory Bowel Disease V: Surgical Management
145
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
145
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
207
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
207
Drugs for Treatment of Diarrhea-Predominant IBS
161
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
161


